Biohaven Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BHVN New York 2830 www.biohaven.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biohaven Ltd.

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - Jul 17th, 2025 8:38 am
Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform - Jul 15th, 2025 6:59 am
Biohaven Insiders Added US$6.28m Of Stock To Their Holdings - Jun 12th, 2025 8:55 am
Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development - Jun 10th, 2025 12:00 pm
Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor - May 29th, 2025 5:01 am
Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy - May 28th, 2025 10:16 pm
Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN) - May 28th, 2025 1:00 pm
Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors - May 28th, 2025 5:30 am
Why Biohaven Stock Dove by Nearly 20% on Thursday - May 15th, 2025 4:03 pm
Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug - May 15th, 2025 12:06 pm
Why Is Biohaven Stock Falling On Thursday? - May 15th, 2025 11:22 am
FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia - May 14th, 2025 4:43 pm
Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments - May 12th, 2025 2:05 pm
Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts - May 9th, 2025 6:49 am
Why BioHaven Stock Is Soaring Today - Apr 28th, 2025 11:16 am
Biohaven Announces Investment up to $600 Million by Oberland Capital - Apr 28th, 2025 5:30 am
Biohaven share price undervaluing pipeline potential, says RBC Capital - Apr 26th, 2025 10:10 am
Why Biohaven Stock Plummeted by More Than 15% Today - Apr 25th, 2025 3:10 pm
Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21 - Apr 23rd, 2025 4:12 pm
Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Apr 23rd, 2025 11:02 am